Amidst concerns over the independence of the U.S. Federal Reserve and renewed tariff uncertainties, European markets have been experiencing a downturn, with major indices such as the STOXX Europe 600 Index ending lower. In this climate of economic uncertainty, growth companies with high insider ownership can be particularly attractive, as insider investment often signals confidence in a company's future prospects despite broader market challenges.
Top 10 Growth Companies With High Insider Ownership In Europe
| Name | Insider Ownership | Earnings Growth |
| Pharma Mar (BME:PHM) | 11.8% | 44.2% |
| MedinCell (ENXTPA:MEDCL) | 13.9% | 91% |
| Marinomed Biotech (WBAG:MARI) | 29.7% | 20.2% |
| KebNi (OM:KEBNI B) | 38.4% | 63.7% |
| Elliptic Laboratories (OB:ELABS) | 24.4% | 97.5% |
| CTT Systems (OM:CTT) | 17.5% | 37.9% |
| Circus (XTRA:CA1) | 24.5% | 72.6% |
| CD Projekt (WSE:CDR) | 29.7% | 42.7% |
| Bonesupport Holding (OM:BONEX) | 10.4% | 59.7% |
| Bergen Carbon Solutions (OB:BCS) | 12% | 64.6% |
We're going to check out a few of the best picks from our screener tool.
Floridienne (ENXTBR:FLOB)
Simply Wall St Growth Rating: ★★★★☆☆
Overview: Floridienne S.A. operates through its subsidiaries in the life sciences, food, and chemistry sectors both in Belgium and internationally, with a market cap of €661.16 million.
Operations: The company's revenue is primarily derived from the Life Sciences Division at €507.08 million, followed by the Food sector at €150.96 million, and the Chemicals Division contributing €39.34 million.
Insider Ownership: 19.3%
Floridienne demonstrates potential as a growth company with substantial insider ownership, highlighted by its earnings forecast to grow significantly at 30.9% annually, outpacing the Belgian market's 14.7%. Despite revenue growth being moderate at 11.6%, it still surpasses the local market average of 7.7%. The stock trades well below its estimated fair value, presenting a possible opportunity for investors seeking undervalued assets with strong profit trajectories. Recent dividend increases further underscore financial stability and shareholder returns.
- Navigate through the intricacies of Floridienne with our comprehensive analyst estimates report here.
- Our valuation report unveils the possibility Floridienne's shares may be trading at a premium.
Leonteq (SWX:LEON)
Simply Wall St Growth Rating: ★★★★☆☆
Overview: Leonteq AG is a Swiss company that offers derivative investment products and services across Switzerland, Europe, Asia, and other international markets with a market cap of CHF285.61 million.
Operations: Leonteq AG generates revenue from its brokerage segment, which amounted to CHF227.96 million.
Insider Ownership: 17.7%
Leonteq is positioned for growth with strong insider ownership, despite its volatile share price. The company forecasts earnings growth of 51.98% annually and revenue growth of 12.3%, outpacing the Swiss market's average. Recent strategic partnerships, such as with Emirates Islamic, enhance its product offerings in the Gulf region. Despite a recent dip in net income to CHF 9.26 million for H1 2025, Leonteq remains competitively valued compared to peers and industry standards.
- Delve into the full analysis future growth report here for a deeper understanding of Leonteq.
- Our comprehensive valuation report raises the possibility that Leonteq is priced lower than what may be justified by its financials.
Semperit Holding (WBAG:SEM)
Simply Wall St Growth Rating: ★★★★☆☆
Overview: Semperit Aktiengesellschaft Holding is a company that develops, produces, and sells rubber products for the medical and industrial sectors globally, with a market cap of €271.57 million.
Operations: The company's revenue segments include €364.57 million from Engineered Applications and €287.20 million from Industrial Applications.
Insider Ownership: 10.1%
Semperit Holding, with significant insider ownership, faces challenges as recent earnings show a net loss of EUR 4 million for Q2 2025. Despite this, the company's revenue growth forecast of 7.6% annually surpasses the Austrian market average. Analysts agree on a potential stock price increase of 27%, although profitability is expected only within three years. Trading below estimated fair value and with low return on equity forecasts, Semperit's dividend remains unsustainably covered by earnings.
- Click to explore a detailed breakdown of our findings in Semperit Holding's earnings growth report.
- According our valuation report, there's an indication that Semperit Holding's share price might be on the cheaper side.
Next Steps
- Dive into all 215 of the Fast Growing European Companies With High Insider Ownership we have identified here.
- Ready To Venture Into Other Investment Styles? Outshine the giants: these 24 early-stage AI stocks could fund your retirement.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.
Valuation is complex, but we're here to simplify it.
Discover if Leonteq might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.
Access Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com